Gwenn M. Hansen
Chief Scientific Officer Nurix Therapeutics, Inc.
Seminars
Tuesday 28th October 2025
Clinical Update on Bexobrutideg: The First “-Deg”
12:15 pm

Chief Scientific Officer Nurix Therapeutics, Inc.